Materials and methods for modulating t cell mediated immunity | Patent Publication Number 20210032338

US 20210032338 A1
Patent NumberUS 11667712 B2
Application Number16869401
Filled DateMay 7, 2020
Priority DateMay 8, 2019
Publication DateFeb 4, 2021
Original AssigneeJohnson & Johnson
Current AssigneeJanssen Biotech Inc.
Inventor/ApplicantsSanjaya Singh
Rajkumar Ganesan
Iqbal S. Grewal
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.